Indian physicians’ perception of clinical trials

Phanish Chandra, Radhika Bhave


The successful completion of clinical trials depends largely on the active participation of physicians. Tharyan, P (2007) has discussed at length, the opportunities, obligations, challenges, and solutions of conducting clinical trials in India (2-4). In this regard, an online survey was conducted on Docplexus to measure the physician awareness, understanding, and inclination towards the involvement in conducting clinical trials in India.

Docplexus conducted a survey on 463 doctors specializing in Pharmacology/Clinical Pharmacology, General Medicine, Cardiology, Orthopedics, Neurology and Urology to understand their inclinations and concerns regarding clinical trials in India. A total of 53 doctors completed the survey. The data obtained from the survey was collected and analyzed to evaluate the parameters involved in inclination or aversion of physician participation and deduce perception.


Physicians’ perception, Docplexus, Clinical trials

Full Text:



Kumar UA. India has just one doctor for every 1,700 people. Available at http://www. article1792010.ece. Accessed on 18 March 2016.

National Health Policy, March 2017, Central Drugs Standard Control Organization, Ministry of Health and Family Welfare. Government of India. Accessed on 18 March 2016.

Bajpai V. Rise of Clinical Trials Industry in India: An Analysis. ISRN Public Health. 2013;2013:1-17.

Tharyan P. Ethics committees and clinical trials registration in India: opportunities, obligations, challenges, and solutions. Indian J Med Ethics. 2007;4(4):168-9.

Suvarna Y, Rajagopalan R. Recent changes in regulatory aspect of clinical trials in India. World J Pharm Pharm Sci. 2015;4(7):1948-59.

Bhatt A. Clinical trials in India: Way forward. Perspect Clin Res. 2014;5(2):53-4.

Gogtay NJ, Ravi R, Thatte UM. Regulatory requirements for clinical trials in India: What academicians need to know? Indian J Anaesth. 2017;61(3):192-9.